Skip to main content

Table 2 Response and side effects

From: Low-dose trofosfamide plus rituximab is an effective and safe treatment for diffuse large B-cell lymphoma of the elderly: a single center experience

ID

response

grade III/IV side effects

hematologic

non-hematologic

1

PR

no

no

2

PR

pancytopenia

no

3

CR

leukopenia

no

4

CR

no

no

5

CR

pancytopenia

no

6

CR

no

no

7

SD

no

no

8

CR

leukopenia

no

9

PD

no

no

10

PR

no

no

11

PD

no

no

  1. PR partial response, CR complete response, SD stable disease, PD progressive disease